Provided by Tiger Fintech (Singapore) Pte. Ltd.

TherapeuticsMD

1.25
+0.205019.62%
Post-market: 1.18-0.0700-5.60%19:58 EDT
Volume:8.76M
Turnover:12.45M
Market Cap:14.47M
PE:-29.34
High:1.70
Open:1.07
Low:1.05
Close:1.05
52wk High:2.44
52wk Low:0.7000
Shares:11.57M
Float Shares:9.56M
Volume Ratio:401.89
T/O Rate:91.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0426
EPS(LYR):-0.1891
ROE:-1.98%
ROA:-3.61%
PB:0.53
PE(LYR):-6.61

Loading ...

TherapeuticsMD Inc. Stock Climbs 19.6%, Outperforms Market

Dow Jones
·
Yesterday

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Oct 11

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Oct 07

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 04

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 02

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Sep 26

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 19

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Sep 16

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 11

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Sep 05

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 04

TherapeuticsMD Inc. Stock Sheds 4.5%, Underperforms Market

Dow Jones
·
Sep 03

TherapeuticsMD Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
Aug 23

TherapeuticsMD Inc. Stock Slides 2.7%, Underperforms Market

Dow Jones
·
Aug 22

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 20

TherapeuticsMD Inc. Stock Sheds 2.6%, Underperforms Market

Dow Jones
·
Aug 19

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 16

TherapeuticsMD Reports Q2 2025 Net Income of $545K, EPS of $0.05; License Revenue Increases to $1M

Reuters
·
Aug 13

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 12

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Aug 09